Index
A
abbreviated new drug approvals (ANDA), 56
Adverse Drug Reaction Suffering Relief Fund, 32
Adverse drug reactions (ADRs)
in China, 139–41
in Vietnam, 331–2
Agency for Science, Technology and Research (A*STAR), 200
Asia
clinical research
background, 1–2
boom, 8–13
business, 5–7
cost-effectiveness, 340–1
country segmentation analysis, 15–17
economic environment, 340–1
environmental factors, 347–9
future outlook, 353–4
government incentives, 340
human resources cost, 341
improved infrastructure and processes, 339–40
intellectual property protection norms, 338–9
legal environment, 346–7
local partners, 348–9
patient pool and doctors, 347
PESTLE analysis of, 335–6
political environment, 336–40
regulatory environment, 336–8
regulatory requirements, ...
Get Clinical Research in Asia now with the O’Reilly learning platform.
O’Reilly members experience books, live events, courses curated by job role, and more from O’Reilly and nearly 200 top publishers.
